View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/SAMHSA | RIN: 0930-AA33 | Publication ID: Spring 2023 |
Title: Mandatory Guidelines for Federal Workplace Drug Testing Programs--Hair | |
Abstract:
This action proposes to establish update the scientific and technical guidelines for the inclusion of hair specimens in the Mandatory Guidelines for Federal Workplace Drug Testing Programs and standards for certification of laboratories engaged in drug testing for federal agencies. SAMHSA has chosen to reissue these Guidelines as proposed rather than as final to seek further public comment on unresolved scientific issues related to external contamination and forensic hair testing for drugs, and on changes to align the HMG with the proposed final urine mandatory guidelines (UrMG) and oral fluid mandatory guidelines (OFMG). |
|
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: None (To search for a specific CFR, visit the Code of Federal Regulations.) | |
Legal Authority: sec. 503 of Pub. L. 100-71 5 U.S.C. 7301 E.O. 12564 |
Legal Deadline:
None |
||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Ron Flegel Director, Division of Workplace Programs, CSAP Department of Health and Human Services Substance Abuse and Mental Health Services Administration 5600 Fishers Lane, Room 16N01, Rockville, MD 20857 Phone:240 276-2611 Email: ron.flegel@samhsa.hhs.gov |